Safe discharge of some patients who have taken an overdose of opioids may be possible after one hour

Date First Published:
November 19, 2001
Last Updated:
November 13, 2002
Report by:
Simon Clarke, Specialist Registrar (Royal Oldham Hospital, Lancs, Medical Toxicology Unit, London.)
Search checked by:
Paul Dargan, Royal Oldham Hospital, Lancs, Medical Toxicology Unit, London.
Three-Part Question:
In [patients given naloxone for the treatment of opioid overdose] is [a lack of recurrence of symptoms after one hour] a sensitive predictor for [the patient being able to be safely discharged from the department]?
Clinical Scenario:
A 30 year old opioid addict is brought to the emergency department having overdosed on heroin. He is successfully treated with a titrated bolus of naloxone. You wonder when it will be safe to discharge the patient.
Search Strategy:
Medline 1966-02/02 using the OVID interface.
Search Details:
[{exp narcotics OR opioid.mp OR opiate.mp OR morphine.mp OR buprenorphine.mp OR codeine.mp OR dextromoramide.mp OR diphenoxylate.mp OR dipipanone.mp OR dextropropoxyphene.mp OR diamorphine.mp OR heroin.mp OR alfentanil.mp OR fentanyl.mp OR remifentanil.mp OR meptazinol.mp OR methadone.mp OR nalbuphine.mp OR oxycodone.mp OR pentazocine.mp OR pethidine.mp OR phenazocine.mp OR tramadol.mp} AND {exp overdose OR overdos$.mp OR exp poisons OR poison$.mp OR "acute intoxic$".mp OR "acute toxic$".mp} AND {exp patient admission OR admission.mp OR exp patient discharge OR discharge.mp OR observ$.mp OR monitor$.mp OR predict$.mp}] LIMIT to human AND English.
Outcome:
194 papers were found of which only 5 were relevant to the setting.
Relevant Paper(s):
Study Title Patient Group Study type (level of evidence) Outcomes Key results Study Weaknesses
Is admission after intravenous heroin overdose necessary? Smith DA, Leake L, Loflin JR et al. 1992, USA 124 patients presenting to an ED with a heroin overdose Observational Time to decision 20 mins Treatments given were neither standardised nor randomised so analysis of outcome could not be performed in relation to mode of treatment
Follow-up was poor so it is possible that patients who sought further treatment or who died elsewhere would have been missed
Further treatment after discharge
Patients intoxicated with heroin or heroin mixtures: how long should they be monitored? Osterwalder JJ. 1995, Switzerland 192 patients attending an ED with clinical suspicion of opioid od Observational Time to decision 15 mins No attempt was made to compare the outcomes of different treatment modes
The period of observation in the ED was not recorded
Reattendance if discharged 1 patient died
Opioid toxicity recurrence after an initial response to naloxone. Watson WA, Steele MT, Muelleman RL, et al. 1998, USA 84 patients attending an ED who had been given naloxone for a presumed opioid od Observational Subsequent recurrence of opioid toxicity Patients who have taken a longacting opioid are more likely to experience a recurrence of toxicity No follow-up of patients was attempted after admission to hospital/discharge from the ED to assess the incidence of late complications
The period of observation in the ED was not recorded
Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Vilke GM, Buchanan J, Dunford JV et al. 1999, USA 317 patients with a clinical suspicion of opioid od who refused to be transported to the ED after being given naloxone by the paramedics Observational Reattendence of the ambulance within 12 hours Nil Variable doses and routes of administration of naloxone were used
No follow-up of patients was attempted to ascertain if they received subsequent treatment or died in another area or attended the ED by other means of transport
Death No patients treated with naloxone died
Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Christenson J, Etherington J, Grafstein E, et al. 2000, Canada 573 patients attending an ED with clinical evidence of opioid intoxication who had been given naloxone either in the prehospital setting or ED Observational Clinical prediction rule to predict safe discharge Patients can be safely discharged one hour after administration of naloxone if they have normal mobility, SpO2 >92%, respiratory rate 10-20/min, heart rate 50-100/min, temperature 35-37.5 C, GCS 15/15 The rule has not been validated yet
The pattern of drug abuse in Vancouver is different from other cities, so there are concerns about whether these results can be applied to different populations (eg those that misuse a higher proportion of longer acting agents)
Author Commentary:
The evidence consists of observational studies, three of which are retrospective reviews of medical records and thus there are concerns regarding the reliability of the data collected. In addition, only Christenson's study attempts to apply a "rule-out" strategy by attempting to identify the clinical variables that predict a low risk of delayed complications from the opioid overdose. Futher work is required to validate the rule in different populations by further prospective studies. Also, comparative trials need to be undertaken to assess the validity of the rule for different opiod overdoses.
Bottom Line:
The evidence suggests that if a patient remains well one hour after administration of naloxone, then it is safe to discharge them.
Level of Evidence:
Level 3: Small numbers of small studies or great heterogeneity or very different population
References:
  1. Smith DA, Leake L, Loflin JR et al.. Is admission after intravenous heroin overdose necessary?
  2. Osterwalder JJ.. Patients intoxicated with heroin or heroin mixtures: how long should they be monitored?
  3. Watson WA, Steele MT, Muelleman RL, et al.. Opioid toxicity recurrence after an initial response to naloxone.
  4. Vilke GM, Buchanan J, Dunford JV et al.. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone?
  5. Christenson J, Etherington J, Grafstein E, et al.. Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule.